Healthcare - Biotechnology - NASDAQ - US
$ 0.043
3.61 %
$ 2.34 M
Market Cap
-0.09
P/E
BALANCE SHEET
26.1 M
ASSETS
157 M
LIABILITIES
-131 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Galera Therapeutics, Inc.
| Current Assets | 21.6 M |
| Cash & Short-Term Investments | 18.3 M |
| Receivables | 0 |
| Other Current Assets | 3.37 M |
| Non-Current Assets | 4.51 M |
| Long-Term Investments | 0 |
| PP&E | 1.28 M |
| Other Non-Current Assets | 3.23 M |
| Current Liabilities | 4.96 M |
| Accounts Payable | 1.38 M |
| Short-Term Debt | 266 K |
| Other Current Liabilities | 3.32 M |
| Non-Current Liabilities | 152 M |
| Long-Term Debt | 1.12 M |
| Other Non-Current Liabilities | 151 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 18.3 | 4.3 | 19.9 | 15.9 | 18.4 | 14.8 | 6.2 |
| Short Term Investments | 0 | 27.3 | 51.4 | 56.9 | 93.9 | 66.7 | 8.0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0.9 | 0.5 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 3.4 | 6.9 | 12.3 | 10.3 | 10.6 | 1.5 | 0.5 |
| Total Current Assets | 21.6 | 38.5 | 77.4 | 77.9 | 117.6 | 83.9 | 15.2 |
| PP&E | 1.3 | 0.5 | 0.8 | 1.6 | 1.7 | 0.6 | 0.3 |
| Intangible Assets | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 |
| Goodwill | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 90 K | 1.9 | 2.0 | 1.5 | 0.9 | 0.5 | 0.2 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 26.1 | 44.0 | 83.3 | 84.1 | 123.4 | 88.1 | 18.9 |
| LIABILITIES | |||||||
| Accounts Payable | 1.4 | 3.6 | 5.0 | 5.1 | 3.9 | 3.9 | 2.3 |
| Short Term Debt | 0.3 | 88 K | 0.5 | 0.5 | 0.6 | 0 | 0 |
| Other Current Liabilities | 3.3 | 9.7 | 7.4 | 8.3 | 5.2 | 2.6 | 2.0 |
| Total Current Liabilities | 5.0 | 13.4 | 12.9 | 14.0 | 9.7 | 6.4 | 4.3 |
| Long Term Debt | 1.1 | 139.6 | 44 K | 0.6 | 1.1 | 20.2 | 0 |
| Deferred Tax Income | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.5 |
| Other Liabilities | 151.0 | 0 | 128.1 | 63.1 | 42.7 | 165.9 | 90.2 |
| Total Liabilities | 157.3 | 153.2 | 141.3 | 78.0 | 53.8 | 192.9 | 95.0 |
| EQUITY | |||||||
| Common Stock | 54 K | 28 K | 26 K | 25 K | 25 K | 2 K | 2 K |
| Retained Earnings | (437.4) | (378.3) | (316.1) | (235.6) | (161.3) | (104.8) | (76.1) |
| Other Accumulative Comprehensive Income/Loss | 0 | 22 K | 14 K | 12 K | 38 K | 3 K | 3 K |
| Total Equity | (131.2) | (109.2) | (58.0) | 6.1 | 69.6 | (104.8) | (76.1) |
| Total Liabilities and Equity | 26.1 | 44.0 | 83.3 | 84.1 | 123.4 | 88.1 | 18.9 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 44.5 | 27.1 | 25.8 | 24.9 | 24.8 | 19.4 | 15.2 |